Efficacy and safety of intranasal dexmedetomidine vs. oral chloral hydrate sedation for transthoracic echocardiography in infants with congenital heart disease aged under 3 months: a retrospective study
Frontiers in Pediatrics · 25.06.2026 · 14
DOI: 10.3389/fped.2026.1840343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 25.06.2026. Verfasst von Jingjing Lv und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The procedural sedation for young children, especially in infants under 3 months old, and those with congenital heart disease (CHD) is relatively challenging and risky. This study compares the efficacy and safety of intranasal dexmedetomidine and oral chloral hydrate for sedation in these special populations and identifies the risk factors that influencing sedation success.
Methods
This retrospective study included infants with CHD aged under 3 months who underwent outpatient sedation for transthoracic echocardiography (TTE) from January 2023 to January 2024. Sedation was administered as either intranasal dexmedetomidine (Dex) 2 μg/kg or oral chloral hydrate (50 mg/kg). Failure to achieve adequate sedation with the initial dose was defined as initial sedation failure. Ultimate sedation failure was determined if TTE examination remained incomplete despite rescue interventions. Data including heart rate (HR), pulse oxygen saturation (SpO 2 ), sedation onset time, discharge time, and adverse reactions were collected. The primary outcomes were the initial sedation success rate. The groups were compared using propensity score matching (PSM) analysis. While the secondary outcome was the risk factors that influencing initial and overall sedation success.
Results
A total of 383 patients were included in the final analysis. The initial sedation success rate and the overall success rate were higher in the Dex 2 μg/kg group than in the chloral hydrate group before and after PSM. The sedation onset time and the discharge time in the Dex 2 μg/kg group was significantly shorter than those in the chloral hydrate group. The decline of HR in the Dex 2 μg/kg group was greater than that in the chloral hydrate group both before and after PSM. No severe adverse reactions occurred. Children with low body weight and prolonged fasting time were independent risk factors that influencing sedation success rate.
Conclusions
Compared with oral chloral hydrate, the use of intranasal dexmedetomidine of 2 μg/kg was related to a significantly higher success rate of sedation without increasing severe adverse events in infants with CHD aged under 3 months. Prolonged fasting time and low body weight may significantly affect sedation success.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zitieren
APA
Lv, J., & Jin, L. (2026). Efficacy and safety of intranasal dexmedetomidine vs. oral chloral hydrate sedation for transthoracic echocardiography in infants with congenital heart disease aged under 3 months: a retrospective study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1840343
Vancouver
Lv J, Jin L. Efficacy and safety of intranasal dexmedetomidine vs. oral chloral hydrate sedation for transthoracic echocardiography in infants with congenital heart disease aged under 3 months: a retrospective study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1840343
BibTeX
@article{Lv2026,
author = {Lv, Jingjing and Jin, Lihong},
title = {Efficacy and safety of intranasal dexmedetomidine vs. oral chloral hydrate sedation for transthoracic echocardiography in infants with congenital heart disease aged under 3 months: a retrospective study},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1840343}
}
EUVIMED